Literature DB >> 12205710

Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons.

Bassem F El-Khodor1, Robert E Burke.   

Abstract

There is growing evidence that programmed cell death may play a role in degenerative neurologic disease. The caspases are a family of cell death proteins that mediate proteolytic cascades in the death process. Although there is clear evidence that caspases play a role in the destruction of the components of the neuronal soma, it has been controversial whether they play a role in the degeneration of axons that accompanies the death of the cell body. It is important to define the molecular mechanisms of axonal degeneration, because terminal degeneration may occur early in neurodegenerative disease. We have therefore investigated whether caspases play a role in axonal degeneration in the dopaminergic nigrostriatal system following axotomy of the median forebrain bundle during development. We find that this lesion induces apoptosis in midbrain dopaminergic neurons at the level of the cell soma. Concomitantly with this induction of apoptosis, degeneration of dopaminergic axons occurs and is characterized by the formation of axonal swellings and spheroids. Immunohistochemical analysis reveals that the activated form of caspase-3 and a caspase cleavage product of beta-actin are abundantly expressed in these degenerating fibers. We conclude that caspases are activated in degenerating dopaminergic axons as the somata undergo programmed cell death in this model. These results raise the possibility that caspase activation may occur in other programmed cell death contexts for these neurons, and, if this is so, then their inhibition may be a useful therapeutic target. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205710     DOI: 10.1002/cne.10367

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  19 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

2.  Differential effects of AMPA receptor activation on survival and neurite integrity during neuronal development.

Authors:  M Chiara Manzini; Donald J Joseph; Amy B MacDermott; Carol A Mason
Journal:  Mol Cell Neurosci       Date:  2007-03-24       Impact factor: 4.314

3.  Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B.

Authors:  Vincent Ries; Hsiao-Chun Cheng; Amy Baohan; Tatyana Kareva; Tinmarla F Oo; Margarita Rzhetskaya; Ross J Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurochem       Date:  2009-04-16       Impact factor: 5.372

4.  Disconnection of the ascending arousal system in traumatic coma.

Authors:  Brian L Edlow; Robin L Haynes; Emi Takahashi; Joshua P Klein; Peter Cummings; Thomas Benner; David M Greer; Steven M Greenberg; Ona Wu; Hannah C Kinney; Rebecca D Folkerth
Journal:  J Neuropathol Exp Neurol       Date:  2013-06       Impact factor: 3.685

5.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Authors:  Robert M Silva; Vincent Ries; Tinmarla Frances Oo; Olga Yarygina; Vernice Jackson-Lewis; Elizabeth J Ryu; Phoebe D Lu; Stefan J Marciniak; David Ron; Serge Przedborski; Nikolai Kholodilov; Lloyd A Greene; Robert E Burke
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

6.  Brain-derived neurotrophic factor regulates early postnatal developmental cell death of dopamine neurons of the substantia nigra in vivo.

Authors:  Tinmarla F Oo; Deanna M Marchionini; Olga Yarygina; Paul D O'Leary; Richard A Hughes; Nikolai Kholodilov; Robert E Burke
Journal:  Mol Cell Neurosci       Date:  2009-05-03       Impact factor: 4.314

7.  Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin.

Authors:  Robin L Haynes; Saraid S Billiards; Natalia S Borenstein; Joseph J Volpe; Hannah C Kinney
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

8.  Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.

Authors:  Yanping Li; Wencheng Liu; Tinmarla F Oo; Lei Wang; Yi Tang; Vernice Jackson-Lewis; Chun Zhou; Kindiya Geghman; Mikhail Bogdanov; Serge Przedborski; M Flint Beal; Robert E Burke; Chenjian Li
Journal:  Nat Neurosci       Date:  2009-06-07       Impact factor: 24.884

9.  JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration.

Authors:  Vincent Ries; Robert M Silva; Tinmarla F Oo; Hsiao-Chun Cheng; Margarita Rzhetskaya; Nikolai Kholodilov; Richard A Flavell; Chia-Yi Kuan; Pasko Rakic; Robert E Burke
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

10.  Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.

Authors:  J Wu; M Ohlsson; E A Warner; K K Loo; T X Hoang; R R Voskuhl; L A Havton
Journal:  Neuroscience       Date:  2008-07-26       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.